HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Palliative Care1352 papers

Opioid use disorder

Last edited: 4/23/2026

Overview

Opioid use disorder (OUD) is a chronic condition characterized by compulsive opioid use leading to clinically significant impairment or distress. It encompasses patterns of opioid use that create problems or distress related to their use 1 10.

Diagnosis

Clinical Criteria: Presence of problematic opioid use leading to significant impairment or distress 1 10.

Screening Tools: Use of validated questionnaires like CAGE-AID, though noted to have limitations in identifying nonmedical opioid use 39.

Laboratory Tests: Not typically required for diagnosis, but may include toxicology screens to confirm substance use 1 10.

Management

First-Line Treatments:

- Medication-Assisted Treatment (MAT): Buprenorphine (initial dose varies, typically 4-20 mg sublingual daily) 2 6 11 18. - Methadone: Used under strict supervision, dose individualized 17 18.

Adjunctive Treatments:

- Counseling and Behavioral Therapies: Cognitive-behavioral therapy, contingency management 1 10. - Telehealth and Support Programs: Enhanced access to care and support during emergencies 21 42. - Pain Management: Multimodal approaches to manage chronic pain without reliance on opioids 5 15 22.

Special Populations

Pregnancy: Balancing pain management and OUD treatment; multidisciplinary care recommended 3 8 30 31.

Pediatrics: Focus on intrauterine exposure and developmental impacts; close monitoring of children born to mothers with OUD 33 35 36.

Elderly: Consider age-related changes in pharmacokinetics and pharmacodynamics; cautious opioid prescribing 4 5 29.

Comorbidities: Addressing conditions like chronic pain, mood disorders, and polysubstance use concurrently 55 66.

Key Recommendations

Implement Medication-Assisted Treatment (MAT) with buprenorphine or methadone for OUD, tailored to individual needs 2 17 18 (Evidence: Strong).

Enhance Prescriber Training to improve attitudes and increase utilization of buprenorphine in emergency settings 2 10 21 (Evidence: Moderate).

Utilize Telehealth and Support Programs to maintain continuity of care during public health emergencies 21 42 (Evidence: Moderate).

Multidisciplinary Care Teams for pregnant women with OUD to address both maternal and fetal health 3 8 30 31 (Evidence: Moderate).

Monitor and Manage Comorbid Conditions such as chronic pain and mental health disorders alongside OUD treatment 55 66 (Evidence: Moderate).

References

Showing 100 most recent of 204 indexed papers.

1 Stilley JAW, Benton M, Douglas AE, Kapp JM. Biosurveillance and the Opioid Crisis in Emergency Medicine: Qualitative Study of Physician Perspectives. JMIR formative research 2026. link 2 Bicket MC, Nguyen T, Dahlem G, Dora-Laskey A, Brummett CM, Gunaseelan V et al.. Association between tailored prescriber training and buprenorphine treatment for opioid use disorder among emergency medicine clinicians. The American journal of emergency medicine 2026. link 3 Koester M, Porto A, Lomotey L, Forray A, Yonkers K, Ashley K. Impact of Project ECHO on Obstetric Providers Caring for Pregnant and Postpartum Individuals With Opioid Use Disorder: A Qualitative Analysis. Journal of addiction medicine 2026. link 4 Beiting KJ, Landi AJ, Pravodelov V, Ari M. An age-friendly opioid use disorder (OUD) care workshop: Applying the 5Ms framework. Gerontology & geriatrics education 2026. link 5 Ellis R, Rodin R. Pain Management in the Older Adult with Opioid Use Disorder. Clinics in geriatric medicine 2026. link 6 Hamm ME, Emerson R, Rogal SS, Bulls HW, Nugent SM, Anderson A et al.. Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatment. Journal of substance use and addiction treatment 2026. link 7 London KS, Deschler E, Butt S, Graver S, Figaniak J, Hersh N et al.. Assessing the Cardiac Safety of a Multimodal Protocol for 'Tranq Dope' Withdrawal: A Retrospective QTc Analysis. The American journal of emergency medicine 2026. link 8 Lim G, Carvalho B, George RB, Bateman BT, Brummett CM, Ip VHY et al.. Consensus Statement on Pain Management for Pregnant Patients with Opioid-Use Disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine. Anesthesia and analgesia 2025. link 9 . ACOG Clinical Practice Update: Elimination of the DATA-Waiver Program. Obstetrics and gynecology 2025. link 10 Creighton A, Shecter JD, Kruse M, Wascak K, Murray BP. Effect of opioid use disorder training on the attitudes of emergency medicine providers toward treatment of opioid use disorder. The American journal of emergency medicine 2025. link 11 Torchiano A, Roberts B, Haroz R, Milburn C, Baston K, Heil J et al.. Effects of Emergency Department Training on Buprenorphine Prescribing and Opioid Use Disorder-Associated ED Revisits: Retrospective Cohort Study. The western journal of emergency medicine 2025. link 12 Jones KF, Liou KT, Ashare RL, Worster B, Yeager KA, Merlin J et al.. How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025. link 13 Lent MR, Dugosh KL, Varsani K, Jonsson A, Kung T, Galluzzi KE. Motivation and experiences of individuals with opioid use disorder and chronic pain using medical cannabis for 12 months. Harm reduction journal 2025. link 14 Kondapaka M, Gupta R, Stevenson MH, Balsara K, Rodrigo ME, Sheikh FH et al.. Post-Operative Pain Control Following LVAD Placement in a Patient with Prior History of Opioid Use Disorder: A Case Report. Journal of pain & palliative care pharmacotherapy 2025. link 15 Morrissey PJ, Quinn M, Mikolasko B, Fadale PD. Optimizing Safe Opioid Prescribing: A Paradigm Shift in Buprenorphine Management for Orthopaedic Surgery. The Journal of arthroplasty 2025. link 16 Obert DP, Park GH, Strong K, Schreier DR, Korn E, Troyas C et al.. Repeated High-dose Fentanyl Administration in Rats Reveals Minimal Tolerance to Unconsciousness, Bradycardia, Muscle Rigidity, and Respiratory Depression. Anesthesiology 2025. link 17 Robinson KM, Eum S, Desta Z, Tyndale RF, Gaedigk A, Crist RC et al.. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical pharmacology and therapeutics 2024. link 18 Yakovenko I, Mukaneza Y, Germé K, Belliveau J, Fraleigh R, Bach P et al.. Management of opioid use disorder: 2024 update to the national clinical practice guideline. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2024. link 19 Trøstheim M, Eikemo M. Hyperalgesia in Patients With a History of Opioid Use Disorder: A Systematic Review and Meta-Analysis. JAMA psychiatry 2024. link 20 Karavitaki N, Bettinger JJ, Biermasz N, Christ-Crain M, Gadelha MR, Inder WJ et al.. Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement. Endocrine reviews 2024. link 21 Heil JM, Lassiter JM, Salzman MS, Herring A, Hoppe J, Lynch M et al.. A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2024. link 22 Candelario DM, Dume R, Khan N. Opioid-Associated Emergencies: A Review of Their Management and the Utility of Naloxone. Orthopedic nursing 2024. link 23 Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B et al.. Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ (Clinical research ed.) 2024. link 24 Kolla G, Pauly B, Cameron F, Hobbs H, Ranger C, McCall J et al.. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis. Harm reduction journal 2024. link 25 South AM, Oller D, Lofwall M, Fanucchi LC. Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report. Journal of addiction medicine 2024. link 26 Carnide N, Feng G, Song C, Demers PA, MacLeod JS, Sritharan J. Occupational patterns of opioid-related harms comparing a cohort of formerly injured workers to the general population in Ontario, Canada. Canadian journal of public health = Revue canadienne de sante publique 2024. link 27 Boden LI, Asfaw A, O'Leary PK, Tripodis Y, Busey A, Applebaum KM et al.. Opioid-related mortality after occupational injury in Washington State: accounting for preinjury opioid use. Occupational and environmental medicine 2024. link 28 El Sherbini A, Liblik K, Lee J, Baranchuk A, Zhang S, El-Diasty M. Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature. Trends in cardiovascular medicine 2024. link 29 McNair R, Monaghan M, Montgomery P. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review. Drug and alcohol dependence 2023. link 30 Turner S, Allen VM, Carson G, Graves L, Tanguay R, Green CR et al.. Guideline No. 443b: Opioid Use Throughout Women's Lifespan: Opioid Use in Pregnancy and Breastfeeding. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2023. link 31 Turner S, Allen VM, Graves L, Tanguay R, Green CR, Cook JL. Guideline No. 443a: Opioid Use Throughout Women's Lifespan: Fertility, Contraception, Chronic Pain, and Menopause. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2023. link 32 Wong W. The fragile state of opioid withdrawal. Science signaling 2023. link 33 Beldick SR, Rohde JF, Short VL, Abatemarco DJ, Goyal NK. Pediatric Primary Care Diagnoses Among Children with Intrauterine Opioid Exposure. Journal of health care for the poor and underserved 2023. link 34 Vella A, Savona-Ventura C, Mahmood T. Harmful effects of opioid use in pregnancy: A scientific review commissioned by the European Board and College of obstetrics and gynaecology (EBCOG). European journal of obstetrics, gynecology, and reproductive biology 2023. link 35 Short VL, Gannon M, Sood E, Harris G, Kale A, Abatemarco DJ et al.. Opportunities to Increase Well-Child Care Engagement for Families Affected by Maternal Opioid Use Disorder: Perceptions of Mothers and Clinicians. Academic pediatrics 2023. link 36 Short VL, Abatemarco DJ, Sood E, Hand DJ, Gannon M, Hossain J et al.. The Child Healthcare at MATER Pediatric Study (CHAMPS): a 2-arm cluster randomized control trial of group well child care for mothers in treatment for opioid use disorder and their children. Trials 2023. link 37 Sedney CL, Dekeseredy P, Singh SA, Holbein M. Stigmatizing Language Expressed Towards Individuals With Current or Previous OUD Who Have Pain and Cancer: A Qualitative Study. Journal of pain and symptom management 2023. link 38 Ellerbroek H, Hanssen I, Lathouwers K, Cillessen L, Dekkers S, Veldman SE et al.. Mindfulness-based cognitive therapy for chronic noncancer pain and prescription opioid use disorder: A qualitative pilot study of its feasibility and the perceived process of change. Brain and behavior 2023. link 39 Amaram-Davila J, Bramati P, Gammon L, Mallipeddi T, Jastrzemski O, Clark MD et al.. Deficiencies with CAGE-AID questionnaire in identifying nonmedical opioid use-a report of two cases. Annals of palliative medicine 2023. link 40 Ferguson M, Medley A, Rittenbach K, Brothers TD, Strike C, Ng J et al.. Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method. Harm reduction journal 2022. link 41 . Teletriage in postlockdown practice. The Veterinary record 2022. link 42 Fauteux N. The Growth of Telehealth. The American journal of nursing 2022. link 43 Schoenfeld EM, Soares WE, Schaeffer EM, Gitlin J, Burke K, Westafer LM. "This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2022. link 44 Schneider KE, Rouhani S, Weicker NP, Morris M, Sherman SG. Businesses in high drug use areas as potential sources of naloxone during overdose emergencies. Drug and alcohol dependence 2022. link 45 Downer K, Burgan C, Kezar CE, Galgano SJ. Procedural moderate sedation in patients with opioid addiction and chronic pain: a practical primer for the radiologist. Abdominal radiology (New York) 2022. link 46 Janet Ho J, Jones KF, Sager Z, Neale K, Childers JW, Loggers E et al.. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care. Journal of pain and symptom management 2022. link 47 Mohanti BK. Opioid: Plenitude versus pittance. The National medical journal of India 2022. link 48 Spreen LA, Dittmar EN, Quirk KC, Smith MA. Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy 2022. link 49 Hayes CJ, Goree J, Turpin J, Ortiz H, Smith GR, Gokarakonda SB et al.. Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas. Journal of prevention (2022) 2022. link 50 Ellerbroek H, van den Heuvel SAS, Dahan A, Timmerman H, Kramers C, Schellekens AFA. Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial. Addiction science & clinical practice 2022. link 51 Lösch L, Brown P, van Hunsel F. Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database. Pharmacoepidemiology and drug safety 2022. link 52 Etaee F, Tobin M, Vuppala S, Komaki A, Delisle BP, Di Biase L et al.. Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2022. link 53 Gomes T, Kitchen SA, Tailor L, Men S, Murray R, Bayoumi AM et al.. Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada. Journal of addiction medicine 2022. link 54 Brogdon H, Facer KL, Cox EJ, Carlson RH, Wurzel JF. Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation. Journal of addiction medicine 2022. link 55 Liu S, Nwabueze C, Pan Y, Walter SM, Su B, Xu C et al.. Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients. Western journal of nursing research 2022. link 56 . Medication for Adolescents and Young Adults With Opioid Use Disorder. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2021. link 57 Montague E, Bungum M, Sherman L, Gravenor S, Courtney DM, Czerniak A et al.. Using a sociotechnical systems analysis to evaluate an intervention to improve opioid prescribing in emergency medicine. Applied ergonomics 2021. link 58 Harris BR. Suicide as a hidden contributor to the opioid crisis and the role that primary care and emergency medicine play in addressing it. Preventive medicine 2021. link 59 Pourmand A, Beisenova K, Shukur N, Tebo C, Mortimer N, Mazer-Amirshahi M. A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions. The American journal of emergency medicine 2021. link 60 Henderson R, McInnes A, Mackey L, Bruised Head M, Crowshoe L, Hann J et al.. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies. BMC public health 2021. link 61 Trinh NTH, Singh P, Cerdá M, Bruckner TA. Opioid-related emergencies in New York City after the Great Recession. Journal of substance abuse treatment 2021. link 62 Goodin A, Bae J, Delcher C, Brown J, Roussos-Ross D. Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study. Medicine 2021. link 63 Shah JR, Ramseyer A, Coker J. Peripartum management for women with opioid dependence. Current opinion in anaesthesiology 2021. link 64 Starr MR, Patel LG, Ammar M, Yonekawa Y. Opioids and ophthalmology: review of the current literature. Current opinion in ophthalmology 2021. link 65 Ramanadhan S, Woodhams E, Srikanth P, White KO. Pain medication requirements in patients with opioid use disorder at the time of surgical abortion: An exploratory study. Contraception 2021. link 66 Chua KP, Brummett CM, Ng S, Bohnert ASB. Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. JAMA network open 2021. link 67 Flaherty A, Hossain F, Vercelli A. Meeting at the crossroads of pain and addiction: An ethical analysis of pain management with palliative care for individuals with substance use disorders. Journal of opioid management 2021. link 68 Lagisetty P, Garpestad C, Larkin A, Macleod C, Antoku D, Slat S et al.. Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and alcohol dependence 2021. link 69 Kohan L, Potru S, Barreveld AM, Sprintz M, Lane O, Aryal A et al.. Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Regional anesthesia and pain medicine 2021. link 70 Kemény LV, Robinson KC, Hermann AL, Walker DM, Regan S, Yew YW et al.. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Science advances 2021. link 71 Malik E, Rozner L, Adelson M, Schreiber S, Peles E. The Relation between Changes in Vitamin D and Vitamin B12 Levels, Body Mass Index and Outcome in Methadone Maintenance Treatment Patients. Journal of psychoactive drugs 2021. link 72 Demir B, Ozsoy F, Buyuk A, Altindag A. ECG changes in patients with opioid use disorder; P-QT wave dispersion: a retrospective study. Journal of addictive diseases 2021. link 73 Price S. Opioids: The Forgotten Epidemic?. Texas medicine 2020. link 74 Hatten BW, Cantrill SV, Dubin JS, Ketcham EM, Runde DP, Wall SP et al.. Clinical Policy: Critical Issues Related to Opioids in Adult Patients Presenting to the Emergency Department. Annals of emergency medicine 2020. link 75 Mastarone GL, Wyse JJ, Wilbur ER, Morasco BJ, Saha S, Carlson KF. Barriers to Utilization of Prescription Drug Monitoring Programs Among Prescribing Physicians and Advanced Practice Registered Nurses at Veterans Health Administration Facilities in Oregon. Pain medicine (Malden, Mass.) 2020. link 76 Foster SD, Lee K, Edwards C, Pelullo AP, Khatri UG, Lowenstein M et al.. Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing. Annals of emergency medicine 2020. link 77 Pearce LA, Min JE, Piske M, Zhou H, Homayra F, Slaunwhite A et al.. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. BMJ (Clinical research ed.) 2020. link 78 Pauly B, Wallace B, Pagan F, Phillips J, Wilson M, Hobbs H et al.. Impact of overdose prevention sites during a public health emergency in Victoria, Canada. PloS one 2020. link 79 Evans C, McCullough D, Best K, Yorkgitis BK. Effect of Opioid Prescribing Education for Obstetrics and Gynecology Residents in a Safety-Net Hospital. The Journal of the American Osteopathic Association 2020. link 80 McCauley JL, Swartz AE. Reframing Telehealth: Regulation, Licensing, and Reimbursement in Connected Care. Obstetrics and gynecology clinics of North America 2020. link 81 Ko JY, Tong VT, Haight SC, Terplan M, Snead C, Schulkin J. Obstetrician-gynecologists' practice patterns related to opioid use during pregnancy and postpartum-United States, 2017. Journal of perinatology : official journal of the California Perinatal Association 2020. link 82 Nguemeni Tiako MJ, Culhane J, South E, Srinivas SK, Meisel ZF. Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine. JAMA network open 2020. link 83 Ardeljan LD, Waldfogel JM, Bicket MC, Hunsberger JB, Vecchione TM, Arwood N et al.. Current state of opioid stewardship. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2020. link 84 St Marie B, Broglio K. Managing Pain in the Setting of Opioid Use Disorder. Pain management nursing : official journal of the American Society of Pain Management Nurses 2020. link 85 Herzig SJ, Stefan MS, Pekow PS, Shieh MS, Soares W, Raghunathan K et al.. Risk Factors for Severe Opioid-Related Adverse Events in a National Cohort of Medical Hospitalizations. Journal of general internal medicine 2020. link 86 Panagiotoglou D, McCracken R, Lavergne MR, Strumpf EC, Gomes T, Fischer B et al.. Evaluating the intended and unintended consequences of opioid-prescribing interventions on primary care in British Columbia, Canada: protocol for a retrospective population-based cohort study. BMJ open 2020. link 87 Cheatle MD, Falcone M, Dhingra L, Lerman C. Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. Drug and alcohol dependence 2020. link 88 Asfaw A, Boden LI. Impact of workplace injury on opioid dependence, abuse, illicit use and overdose: a 36-month retrospective study of insurance claims. Occupational and environmental medicine 2020. link 89 Dong XS, Brooks RD, Cain CT. Prescription opioid use and associated factors among US construction workers. American journal of industrial medicine 2020. link 90 Thapa N, Kappus M, Hurt R, Diamond S. Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice. Current gastroenterology reports 2019. link 91 Dunkley CA, Carpenter JE, Murray BP, Sizemore E, Wheatley M, Morgan BW et al.. Retrospective Review of a Novel Approach to Buprenorphine Induction in the Emergency Department. The Journal of emergency medicine 2019. link 92 D'Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH et al.. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implementation science : IS 2019. link 93 Strang J, McDonald R, Campbell G, Degenhardt L, Nielsen S, Ritter A et al.. Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 2019. link 94 Griggs CA, Schulz CJ. A changing landscape of opioid prescribing in emergency medicine. The American journal of emergency medicine 2019. link 95 Marino R, Landau A, Lynch M, Callaway C, Suffoletto B. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?. Addiction (Abingdon, England) 2019. link 96 Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S et al.. National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for Women With Opioid Use Disorder. Obstetrics and gynecology 2019. link 97 Winstanley EL, Stover AN. The Impact of the Opioid Epidemic on Children and Adolescents. Clinical therapeutics 2019. link 98 Salihu HM, Salinas A, Medina I, Krishnaswami J, Aliyu MH. Biopsychosocial determinants of opioid use disorder (OUD) and implications for maternal and child health research: A scoping review. Journal of opioid management 2019. link 99 Dunwoody DR, Jungquist CR, Chang YP, Dickerson SS. The common meanings and shared practices of sedation assessment in the context of managing patients with an opioid: A phenomenological study. Journal of clinical nursing 2019. link 100 Rhee TG, Ross JS, Rosenheck RA, Grau LE, Fiellin DA, Becker WC. Accidental drug overdose deaths in Connecticut, 2012-2018: The rise of polysubstance detection?. Drug and alcohol dependence 2019. link

Original source

[1]
Biosurveillance and the Opioid Crisis in Emergency Medicine: Qualitative Study of Physician Perspectives. — Stilley JAW, Benton M, Douglas AE, Kapp JM JMIR formative research (2026)
[2]
Association between tailored prescriber training and buprenorphine treatment for opioid use disorder among emergency medicine clinicians. — Bicket MC, Nguyen T, Dahlem G, Dora-Laskey A, Brummett CM, Gunaseelan V et al. The American journal of emergency medicine (2026)
[3]
Impact of Project ECHO on Obstetric Providers Caring for Pregnant and Postpartum Individuals With Opioid Use Disorder: A Qualitative Analysis. — Koester M, Porto A, Lomotey L, Forray A, Yonkers K, Ashley K Journal of addiction medicine (2026)
[4]
An age-friendly opioid use disorder (OUD) care workshop: Applying the 5Ms framework. — Beiting KJ, Landi AJ, Pravodelov V, Ari M Gerontology & geriatrics education (2026)
[5]
Pain Management in the Older Adult with Opioid Use Disorder. — Ellis R, Rodin R Clinics in geriatric medicine (2026)
[6]
Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatment. — Hamm ME, Emerson R, Rogal SS, Bulls HW, Nugent SM, Anderson A et al. Journal of substance use and addiction treatment (2026)
[7]
Assessing the Cardiac Safety of a Multimodal Protocol for 'Tranq Dope' Withdrawal: A Retrospective QTc Analysis. — London KS, Deschler E, Butt S, Graver S, Figaniak J, Hersh N et al. The American journal of emergency medicine (2026)
[8]
Consensus Statement on Pain Management for Pregnant Patients with Opioid-Use Disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine. — Lim G, Carvalho B, George RB, Bateman BT, Brummett CM, Ip VHY et al. Anesthesia and analgesia (2025)
[9]
ACOG Clinical Practice Update: Elimination of the DATA-Waiver Program. Obstetrics and gynecology (2025)
[10]
Effect of opioid use disorder training on the attitudes of emergency medicine providers toward treatment of opioid use disorder. — Creighton A, Shecter JD, Kruse M, Wascak K, Murray BP The American journal of emergency medicine (2025)
[11]
Effects of Emergency Department Training on Buprenorphine Prescribing and Opioid Use Disorder-Associated ED Revisits: Retrospective Cohort Study. — Torchiano A, Roberts B, Haroz R, Milburn C, Baston K, Heil J et al. The western journal of emergency medicine (2025)
[12]
How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain. — Jones KF, Liou KT, Ashare RL, Worster B, Yeager KA, Merlin J et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2025)
[13]
Motivation and experiences of individuals with opioid use disorder and chronic pain using medical cannabis for 12 months. — Lent MR, Dugosh KL, Varsani K, Jonsson A, Kung T, Galluzzi KE Harm reduction journal (2025)
[14]
Post-Operative Pain Control Following LVAD Placement in a Patient with Prior History of Opioid Use Disorder: A Case Report. — Kondapaka M, Gupta R, Stevenson MH, Balsara K, Rodrigo ME, Sheikh FH et al. Journal of pain & palliative care pharmacotherapy (2025)
[15]
Optimizing Safe Opioid Prescribing: A Paradigm Shift in Buprenorphine Management for Orthopaedic Surgery. — Morrissey PJ, Quinn M, Mikolasko B, Fadale PD The Journal of arthroplasty (2025)
[16]
Repeated High-dose Fentanyl Administration in Rats Reveals Minimal Tolerance to Unconsciousness, Bradycardia, Muscle Rigidity, and Respiratory Depression. — Obert DP, Park GH, Strong K, Schreier DR, Korn E, Troyas C et al. Anesthesiology (2025)
[17]
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. — Robinson KM, Eum S, Desta Z, Tyndale RF, Gaedigk A, Crist RC et al. Clinical pharmacology and therapeutics (2024)
[18]
Management of opioid use disorder: 2024 update to the national clinical practice guideline. — Yakovenko I, Mukaneza Y, Germé K, Belliveau J, Fraleigh R, Bach P et al. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (2024)
[19]
Hyperalgesia in Patients With a History of Opioid Use Disorder: A Systematic Review and Meta-Analysis. — Trøstheim M, Eikemo M JAMA psychiatry (2024)
[20]
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement. — Karavitaki N, Bettinger JJ, Biermasz N, Christ-Crain M, Gadelha MR, Inder WJ et al. Endocrine reviews (2024)
[21]
A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs. — Heil JM, Lassiter JM, Salzman MS, Herring A, Hoppe J, Lynch M et al. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2024)
[22]
Opioid-Associated Emergencies: A Review of Their Management and the Utility of Naloxone. — Candelario DM, Dume R, Khan N Orthopedic nursing (2024)
[23]
Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. — Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B et al. BMJ (Clinical research ed.) (2024)
[24]
"If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis. — Kolla G, Pauly B, Cameron F, Hobbs H, Ranger C, McCall J et al. Harm reduction journal (2024)
[25]
Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report. — South AM, Oller D, Lofwall M, Fanucchi LC Journal of addiction medicine (2024)
[26]
Occupational patterns of opioid-related harms comparing a cohort of formerly injured workers to the general population in Ontario, Canada. — Carnide N, Feng G, Song C, Demers PA, MacLeod JS, Sritharan J Canadian journal of public health = Revue canadienne de sante publique (2024)
[27]
Opioid-related mortality after occupational injury in Washington State: accounting for preinjury opioid use. — Boden LI, Asfaw A, O'Leary PK, Tripodis Y, Busey A, Applebaum KM et al. Occupational and environmental medicine (2024)
[28]
Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature. — El Sherbini A, Liblik K, Lee J, Baranchuk A, Zhang S, El-Diasty M Trends in cardiovascular medicine (2024)
[29]
Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review. — McNair R, Monaghan M, Montgomery P Drug and alcohol dependence (2023)
[30]
Guideline No. 443b: Opioid Use Throughout Women's Lifespan: Opioid Use in Pregnancy and Breastfeeding. — Turner S, Allen VM, Carson G, Graves L, Tanguay R, Green CR et al. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC (2023)
[31]
Guideline No. 443a: Opioid Use Throughout Women's Lifespan: Fertility, Contraception, Chronic Pain, and Menopause. — Turner S, Allen VM, Graves L, Tanguay R, Green CR, Cook JL Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC (2023)
[32]
The fragile state of opioid withdrawal. — Wong W Science signaling (2023)
[33]
Pediatric Primary Care Diagnoses Among Children with Intrauterine Opioid Exposure. — Beldick SR, Rohde JF, Short VL, Abatemarco DJ, Goyal NK Journal of health care for the poor and underserved (2023)
[34]
Harmful effects of opioid use in pregnancy: A scientific review commissioned by the European Board and College of obstetrics and gynaecology (EBCOG). — Vella A, Savona-Ventura C, Mahmood T European journal of obstetrics, gynecology, and reproductive biology (2023)
[35]
Opportunities to Increase Well-Child Care Engagement for Families Affected by Maternal Opioid Use Disorder: Perceptions of Mothers and Clinicians. — Short VL, Gannon M, Sood E, Harris G, Kale A, Abatemarco DJ et al. Academic pediatrics (2023)
[36]
The Child Healthcare at MATER Pediatric Study (CHAMPS): a 2-arm cluster randomized control trial of group well child care for mothers in treatment for opioid use disorder and their children. — Short VL, Abatemarco DJ, Sood E, Hand DJ, Gannon M, Hossain J et al. Trials (2023)
[37]
Stigmatizing Language Expressed Towards Individuals With Current or Previous OUD Who Have Pain and Cancer: A Qualitative Study. — Sedney CL, Dekeseredy P, Singh SA, Holbein M Journal of pain and symptom management (2023)
[38]
Mindfulness-based cognitive therapy for chronic noncancer pain and prescription opioid use disorder: A qualitative pilot study of its feasibility and the perceived process of change. — Ellerbroek H, Hanssen I, Lathouwers K, Cillessen L, Dekkers S, Veldman SE et al. Brain and behavior (2023)
[39]
Deficiencies with CAGE-AID questionnaire in identifying nonmedical opioid use-a report of two cases. — Amaram-Davila J, Bramati P, Gammon L, Mallipeddi T, Jastrzemski O, Clark MD et al. Annals of palliative medicine (2023)
[40]
Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method. — Ferguson M, Medley A, Rittenbach K, Brothers TD, Strike C, Ng J et al. Harm reduction journal (2022)
[41]
Teletriage in postlockdown practice. The Veterinary record (2022)
[42]
The Growth of Telehealth. — Fauteux N The American journal of nursing (2022)
[43]
"This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine. — Schoenfeld EM, Soares WE, Schaeffer EM, Gitlin J, Burke K, Westafer LM Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2022)
[44]
Businesses in high drug use areas as potential sources of naloxone during overdose emergencies. — Schneider KE, Rouhani S, Weicker NP, Morris M, Sherman SG Drug and alcohol dependence (2022)
[45]
Procedural moderate sedation in patients with opioid addiction and chronic pain: a practical primer for the radiologist. — Downer K, Burgan C, Kezar CE, Galgano SJ Abdominal radiology (New York) (2022)
[46]
Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care. — Janet Ho J, Jones KF, Sager Z, Neale K, Childers JW, Loggers E et al. Journal of pain and symptom management (2022)
[47]
Opioid: Plenitude versus pittance. — Mohanti BK The National medical journal of India (2022)
[48]
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. — Spreen LA, Dittmar EN, Quirk KC, Smith MA Pharmacotherapy (2022)
[49]
Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas. — Hayes CJ, Goree J, Turpin J, Ortiz H, Smith GR, Gokarakonda SB et al. Journal of prevention (2022) (2022)
[50]
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial. — Ellerbroek H, van den Heuvel SAS, Dahan A, Timmerman H, Kramers C, Schellekens AFA Addiction science & clinical practice (2022)
[51]
Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database. — Lösch L, Brown P, van Hunsel F Pharmacoepidemiology and drug safety (2022)
[52]
Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article. — Etaee F, Tobin M, Vuppala S, Komaki A, Delisle BP, Di Biase L et al. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2022)
[53]
Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada. — Gomes T, Kitchen SA, Tailor L, Men S, Murray R, Bayoumi AM et al. Journal of addiction medicine (2022)
[54]
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation. — Brogdon H, Facer KL, Cox EJ, Carlson RH, Wurzel JF Journal of addiction medicine (2022)
[55]
Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients. — Liu S, Nwabueze C, Pan Y, Walter SM, Su B, Xu C et al. Western journal of nursing research (2022)
[56]
Medication for Adolescents and Young Adults With Opioid Use Disorder. The Journal of adolescent health : official publication of the Society for Adolescent Medicine (2021)
[57]
Using a sociotechnical systems analysis to evaluate an intervention to improve opioid prescribing in emergency medicine. — Montague E, Bungum M, Sherman L, Gravenor S, Courtney DM, Czerniak A et al. Applied ergonomics (2021)
[58]
Suicide as a hidden contributor to the opioid crisis and the role that primary care and emergency medicine play in addressing it. — Harris BR Preventive medicine (2021)
[59]
A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions. — Pourmand A, Beisenova K, Shukur N, Tebo C, Mortimer N, Mazer-Amirshahi M The American journal of emergency medicine (2021)
[60]
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies. — Henderson R, McInnes A, Mackey L, Bruised Head M, Crowshoe L, Hann J et al. BMC public health (2021)
[61]
Opioid-related emergencies in New York City after the Great Recession. — Trinh NTH, Singh P, Cerdá M, Bruckner TA Journal of substance abuse treatment (2021)
[62]
Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study. — Goodin A, Bae J, Delcher C, Brown J, Roussos-Ross D Medicine (2021)
[63]
Peripartum management for women with opioid dependence. — Shah JR, Ramseyer A, Coker J Current opinion in anaesthesiology (2021)
[64]
Opioids and ophthalmology: review of the current literature. — Starr MR, Patel LG, Ammar M, Yonekawa Y Current opinion in ophthalmology (2021)
[65]
Pain medication requirements in patients with opioid use disorder at the time of surgical abortion: An exploratory study. — Ramanadhan S, Woodhams E, Srikanth P, White KO Contraception (2021)
[66]
Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. — Chua KP, Brummett CM, Ng S, Bohnert ASB JAMA network open (2021)
[67]
Meeting at the crossroads of pain and addiction: An ethical analysis of pain management with palliative care for individuals with substance use disorders. — Flaherty A, Hossain F, Vercelli A Journal of opioid management (2021)
[68]
Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. — Lagisetty P, Garpestad C, Larkin A, Macleod C, Antoku D, Slat S et al. Drug and alcohol dependence (2021)
[69]
Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. — Kohan L, Potru S, Barreveld AM, Sprintz M, Lane O, Aryal A et al. Regional anesthesia and pain medicine (2021)
[70]
Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. — Kemény LV, Robinson KC, Hermann AL, Walker DM, Regan S, Yew YW et al. Science advances (2021)
[71]
The Relation between Changes in Vitamin D and Vitamin B12 Levels, Body Mass Index and Outcome in Methadone Maintenance Treatment Patients. — Malik E, Rozner L, Adelson M, Schreiber S, Peles E Journal of psychoactive drugs (2021)
[72]
ECG changes in patients with opioid use disorder; P-QT wave dispersion: a retrospective study. — Demir B, Ozsoy F, Buyuk A, Altindag A Journal of addictive diseases (2021)
[73]
Opioids: The Forgotten Epidemic? — Price S Texas medicine (2020)
[74]
Clinical Policy: Critical Issues Related to Opioids in Adult Patients Presenting to the Emergency Department. — Hatten BW, Cantrill SV, Dubin JS, Ketcham EM, Runde DP, Wall SP et al. Annals of emergency medicine (2020)
[75]
Barriers to Utilization of Prescription Drug Monitoring Programs Among Prescribing Physicians and Advanced Practice Registered Nurses at Veterans Health Administration Facilities in Oregon. — Mastarone GL, Wyse JJ, Wilbur ER, Morasco BJ, Saha S, Carlson KF Pain medicine (Malden, Mass.) (2020)
[76]
Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing. — Foster SD, Lee K, Edwards C, Pelullo AP, Khatri UG, Lowenstein M et al. Annals of emergency medicine (2020)
[77]
Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. — Pearce LA, Min JE, Piske M, Zhou H, Homayra F, Slaunwhite A et al. BMJ (Clinical research ed.) (2020)
[78]
Impact of overdose prevention sites during a public health emergency in Victoria, Canada. — Pauly B, Wallace B, Pagan F, Phillips J, Wilson M, Hobbs H et al. PloS one (2020)
[79]
Effect of Opioid Prescribing Education for Obstetrics and Gynecology Residents in a Safety-Net Hospital. — Evans C, McCullough D, Best K, Yorkgitis BK The Journal of the American Osteopathic Association (2020)
[80]
Reframing Telehealth: Regulation, Licensing, and Reimbursement in Connected Care. — McCauley JL, Swartz AE Obstetrics and gynecology clinics of North America (2020)
[81]
Obstetrician-gynecologists' practice patterns related to opioid use during pregnancy and postpartum-United States, 2017. — Ko JY, Tong VT, Haight SC, Terplan M, Snead C, Schulkin J Journal of perinatology : official journal of the California Perinatal Association (2020)
[82]
Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine. — Nguemeni Tiako MJ, Culhane J, South E, Srinivas SK, Meisel ZF JAMA network open (2020)
[83]
Current state of opioid stewardship. — Ardeljan LD, Waldfogel JM, Bicket MC, Hunsberger JB, Vecchione TM, Arwood N et al. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2020)
[84]
Managing Pain in the Setting of Opioid Use Disorder. — St Marie B, Broglio K Pain management nursing : official journal of the American Society of Pain Management Nurses (2020)
[85]
Risk Factors for Severe Opioid-Related Adverse Events in a National Cohort of Medical Hospitalizations. — Herzig SJ, Stefan MS, Pekow PS, Shieh MS, Soares W, Raghunathan K et al. Journal of general internal medicine (2020)
[86]
Evaluating the intended and unintended consequences of opioid-prescribing interventions on primary care in British Columbia, Canada: protocol for a retrospective population-based cohort study. — Panagiotoglou D, McCracken R, Lavergne MR, Strumpf EC, Gomes T, Fischer B et al. BMJ open (2020)
[87]
Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. — Cheatle MD, Falcone M, Dhingra L, Lerman C Drug and alcohol dependence (2020)
[88]
Impact of workplace injury on opioid dependence, abuse, illicit use and overdose: a 36-month retrospective study of insurance claims. — Asfaw A, Boden LI Occupational and environmental medicine (2020)
[89]
Prescription opioid use and associated factors among US construction workers. — Dong XS, Brooks RD, Cain CT American journal of industrial medicine (2020)
[90]
Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice. — Thapa N, Kappus M, Hurt R, Diamond S Current gastroenterology reports (2019)
[91]
Retrospective Review of a Novel Approach to Buprenorphine Induction in the Emergency Department. — Dunkley CA, Carpenter JE, Murray BP, Sizemore E, Wheatley M, Morgan BW et al. The Journal of emergency medicine (2019)
[92]
Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). — D'Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH et al. Implementation science : IS (2019)
[93]
Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. — Strang J, McDonald R, Campbell G, Degenhardt L, Nielsen S, Ritter A et al. Drugs (2019)
[94]
A changing landscape of opioid prescribing in emergency medicine. — Griggs CA, Schulz CJ The American journal of emergency medicine (2019)
[95]
Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose? — Marino R, Landau A, Lynch M, Callaway C, Suffoletto B Addiction (Abingdon, England) (2019)
[96]
National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for Women With Opioid Use Disorder. — Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S et al. Obstetrics and gynecology (2019)
[97]
The Impact of the Opioid Epidemic on Children and Adolescents. — Winstanley EL, Stover AN Clinical therapeutics (2019)
[98]
Biopsychosocial determinants of opioid use disorder (OUD) and implications for maternal and child health research: A scoping review. — Salihu HM, Salinas A, Medina I, Krishnaswami J, Aliyu MH Journal of opioid management (2019)
[99]
The common meanings and shared practices of sedation assessment in the context of managing patients with an opioid: A phenomenological study. — Dunwoody DR, Jungquist CR, Chang YP, Dickerson SS Journal of clinical nursing (2019)
[100]
Accidental drug overdose deaths in Connecticut, 2012-2018: The rise of polysubstance detection? — Rhee TG, Ross JS, Rosenheck RA, Grau LE, Fiellin DA, Becker WC Drug and alcohol dependence (2019)

Share:Twitter Reddit LinkedIn